•  
  •  
  •  
  •  

2025-10-02 13:43:11

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  Nava

Stock Report

  • Nava Ltd recommends final dividend of Rs. 6
  • Nava Ltd Q4 FY2024-25 consolidated profit at Rs. 234.40 crores
  • Maamba Collieries Ltd receives exploration licenses for Lithium and other minerals in Zambia
  • NAVA Ltd announces routine maintenance at 60 MW captive power plant
  • Nava Ltd consolidated Q3 FY24 net profit surges to Rs. 328.20 crores
  • Business interruption in Odisha works of Nava Limited
  • NAVA Ltd Q1FY24 consolidated PAT up QoQ at Rs. 261.05 crores
  • Nava Limited announces remarkable turnaround with Debt Reduction and Enhanced Cash Flows
  • Maamba Collieries Limited, Zambia discharges overdue loan instalments
  • Nava Ltd recommends final dividend of Rs. 6
  • NAVA Ltd consolidated Q4 FY2022-23 net profit at Rs. 246.65 crores
  • Nava Ltd updates on consent arbitral award for Maamba Collieries Limited, Zambia
  • NAVA Ltd Q3 FY2023 consolidated profit jumps to Rs. 245.04 crores
  • Nava Ltd's subsidiary gets 1st payment of $10 mn as per arbitration proceedings
  • Maamba Collieries Ltd updates on arbitration against ZESCO
  • NAVA Ltd updates on shutdown of Ferro Alloy Plant
  • NAVA Ltd announces maintenance shutdown of 150MW power plant of subsidiary
  • Maamba Collieries Ltd secures membership of Southern African Power Pool
  • NAVA Ltd Q2FY23 consolidated PAT falls QoQ to Rs. 137.36 crores
  • Nava Ltd to discontinue conversion agreement with TATA Steel Mining Ltd

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024